2OJ9
Structure of IGF-1R kinase domain complexed with a benzimidazole inhibitor
Summary for 2OJ9
Entry DOI | 10.2210/pdb2oj9/pdb |
Descriptor | Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen), 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE (3 entities in total) |
Functional Keywords | hormone/growth factor, igf-1r, kinase domain, transferase |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P08069 |
Total number of polymer chains | 1 |
Total formula weight | 35438.66 |
Authors | Sack, J.S.,Jacobson, B.L. (deposition date: 2007-01-12, release date: 2007-05-01, Last modification date: 2023-12-27) |
Primary citation | Velaparthi, U.,Wittman, M.,Liu, P.,Stoffan, K.,Zimmermann, K.,Sang, X.,Carboni, J.,Li, A.,Attar, R.,Gottardis, M.,Greer, A.,Chang, C.Y.,Jacobsen, B.L.,Sack, J.S.,Sun, Y.,Langley, D.R.,Balasubramanian, B.,Vyas, D. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R). Bioorg.Med.Chem.Lett., 17:2317-2321, 2007 Cited by PubMed: 17317169DOI: 10.1016/j.bmcl.2007.01.102 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report